Arch Biopartners Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Jan '25 Jan 3, 2025	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	2018 - 2014
Market Capitalization	129	69	187	107	81	57	Upgrade
Market Cap Growth	-13.14%	-63.23%	75.09%	31.57%	41.78%	-38.99%	Upgrade
Enterprise Value	135	74	191	112	83	59	Upgrade
Last Close Price	2.00	1.09	3.01	1.71	1.37	0.99	Upgrade
PS Ratio	77.54	34.58	193.39	27.41	1192.93	608.45	Upgrade
PB Ratio	-16.36	-12.45	-41.73	-27.44	-20.94	-21.66	Upgrade
P/FCF Ratio	-	-	389.08	-	-	-	Upgrade
P/OCF Ratio	-	-	389.08	-	-	-	Upgrade
EV/Sales Ratio	92.35	37.12	197.59	28.88	1222.05	630.94	Upgrade
EV/FCF Ratio	-	-	397.54	-	-	-	Upgrade
Debt / Equity Ratio	-0.81	-0.91	-0.99	-1.33	-0.88	-1.09	Upgrade
Debt / FCF Ratio	-	-	9.20	-	-	-	Upgrade
Asset Turnover	0.94	2.21	0.59	2.28	0.09	0.11	Upgrade
Quick Ratio	0.20	0.19	0.21	0.83	0.59	0.92	Upgrade
Current Ratio	0.20	0.20	0.22	0.84	0.61	1.42	Upgrade
Return on Assets (ROA)	-81.20%	-201.92%	-37.88%	-30.04%	-347.68%	-141.73%	Upgrade
Return on Capital (ROIC)	-	-	-101.86%	-127.43%	-	-289.87%	Upgrade
Earnings Yield	-2.01%	-4.85%	-0.75%	-1.10%	-5.72%	-3.66%	Upgrade
FCF Yield	-2.53%	-0.34%	0.26%	-2.80%	-2.35%	-3.16%	Upgrade
Buyback Yield / Dilution	-2.27%	-0.49%	-1.36%	-2.34%	-2.18%	-2.84%	Upgrade
Total Shareholder Return	-2.27%	-0.49%	-1.36%	-2.34%	-2.18%	-2.84%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.